Trial Profile
The United Kingdom Glaucoma Treatment Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Latanoprost (Primary)
- Indications Open-angle glaucoma
- Focus Therapeutic Use
- Acronyms UKGTS
- Sponsors Pfizer
- 11 Dec 2015 Results published in the Lancet
- 11 Dec 2015 New trial record